前收市價 | 4.4000 |
開市 | 4.4000 |
買盤 | 0.5500 |
賣出價 | 1.5000 |
拍板 | 155.00 |
到期日 | 2024-09-20 |
今日波幅 | 4.4000 - 4.4000 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 6 |
Finding overlooked stocks (worth investing in) is tough in today’s market. While you can screen for micro-caps, pink sheet stocks, and similar speculative investments, most of the best blue-chip and long-term stocks are well-known and heavily invested in. Still, a handful of overlooked stocks remain viable, even as tight economic conditions force investors to stack cash or go with reliable index investing. These overlooked stocks blend growth, stability and income while spanning multiple market
Jazz (JAZZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Now that the federal government is finally taking action on cannabis rescheduling — moving it to Schedule III and creating de facto medical cannabis legalization — many are wondering about the status of cannabis stocks as a whole. Cannabis stocks, as a whole, spiked upwards on the news but quickly reverted to pre-announcement norms. That’s because creating a medical mandate for cannabis may prove more disruptive to the status quo than expected (and not in a good way) — but the uncertainty create